Cytomx Therapeutics Inc (CTMX)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
CytomX Therapeutics* Trailblazing Potential: Unveiling the Future of Cancer Therapeutics
The company reported an unexpected accomplishment, over the second quarter of 2023
Cytomx Therapeutics Inc Makes a Remarkable Comeback with Stellar Q1 2023 Earnings
A loss of $-0.42 per Share at the Cytomx Therapeutics Inc in fourth quarter of 2022
The company declared a -3.821 %, reduction in revenue, all along the third quarter of 2022